Tolerance induction at the early maternal-placental interface through selective cell recruitment and targeting by immune polypeptides

Am J Reprod Immunol. 2013 Apr;69(4):359-68. doi: 10.1111/aji.12087. Epub 2013 Feb 14.

Abstract

Pregnancy challenges immune cells and immunomodulatory circuits of the mother and the developing fetus to dynamically adapt to each other in an homeostatic and tolerant environment for fetal growth. This entails the coordination of multiple cellular processes all devoted to accommodate and nourish the fetus while protecting the mother from endogenous and exogenous threatens. From the earliest stages of pregnancy, several strategies to efficiently communicate immune and trophoblast cells within the interface or at a distance were identified and chemokines might act at on different targets through direct or indirect mechanisms. Here, we briefly review some mechanisms of T regulatory cell recruitment to the early maternal-placental interfaces to accomplish immunotolerance and homeostatic control and we discuss evidence on two locally released polypeptides, RANTES (regulated on activation, normal, T-cell expressed, and secreted) and vasoactive intestinal peptide (VIP), as novel contributors to the multiplicity of immune tolerant responses and uterine quiescence requirements.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Chemokine CCL5 / metabolism
  • Chemokines / metabolism
  • Female
  • Fetus / immunology*
  • Humans
  • Immune Tolerance*
  • Lymphocyte Activation
  • Placenta / immunology*
  • Pregnancy / immunology*
  • T-Lymphocytes, Regulatory / immunology*
  • Trophoblasts / immunology
  • Vasoactive Intestinal Peptide / metabolism

Substances

  • CCL5 protein, human
  • Chemokine CCL5
  • Chemokines
  • Vasoactive Intestinal Peptide